The effect of a topical vitamin D3 analog on repigmentation in mice with rhododendrol-induced leukoderma

J Dermatol Sci. 2022 May;106(2):127-129. doi: 10.1016/j.jdermsci.2022.04.005. Epub 2022 Apr 14.

Authors

Yuko Abe¹, Ken Okamura², Shosuke Ito³, Yutaka Hozumi², Tamio Suzuki²

Affiliations

¹ Department of Dermatology, Yamagata University Faculty of Medicine, Yamagata, Japan. Electronic address: a.yuko@med.id.yamagata-u.ac.jp.
² Department of Dermatology, Yamagata University Faculty of Medicine, Yamagata, Japan.
³ Institute for Melanin Chemistry, Fujita Health University, Aichi, Japan.

PMID: 35487790
DOI: 10.1016/j.jdermsci.2022.04.005

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Butanols / adverse effects
Cholecalciferol
Hypopigmentation* / chemically induced
Hypopigmentation* / drug therapy
Mice

Substances

Butanols
rhododendrol
Cholecalciferol